Compare Innovative Industrial Properties Inc (IIPR) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innovative Industrial Properties Inc vs Repligen Corporation Common Stock — how do they compare? Innovative Industrial Properties Inc trades at $51.47 (market cap $1.42B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Repligen Corporation Common Stock is far larger — about 7.8× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays a 14.74% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Innovative Industrial Properties Inc for 87 Days and Repligen Corporation Common Stock for 0 Days on average.
| IIPR | RGEN | |
|---|---|---|
Market Cap | $1.42B | $11.14B |
Volume | 427,967 | 1,259,263 |
Sector | Real Estate | Health |
52-Week High | $64.67 | $194.57 |
52-Week Low | $44.58 | $102.87 |
Typical Hold Time | 87 Days | 0 Days |
Enterprise Value | $1.95B | $11.02B |
Dividend Yield | 14.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $51.43, up 0.47% on the day, exhibiting a bearish technical trend near key support at $51. Fundamentally, the REIT shows high gross margins of 88.35% but faces revenue and net income declines in 2025. Recent news highlights a significant $245 million mezzanine loan commitment, signaling active capital deployment despite sector headwinds.
The outlook is mixed; the stock offers a high dividend yield but carries risks from tenant defaults and volatile earnings. Analyst consensus is cautious with a majority Hold rating. Investors should weigh the attractive valuation metrics against operational challenges in the cannabis real estate sector.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
